Market Research Logo

AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

Section 1 - About the Company
AbbVie Inc - Key Facts
AbbVie Inc - Key Employees
AbbVie Inc - Key Employee Biographies
AbbVie Inc - Major Products and Services
AbbVie Inc - Pharmaceutical Pipeline Products Data
AbbVie Inc, Pipeline Products by Therapy Area
AbbVie Inc, Pipeline Products by Development Phase
AbbVie Inc - History
AbbVie Inc - Company Statement
AbbVie Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
AbbVie Inc - Business Description
AbbVie Inc - Corporate Strategy
AbbVie Inc - SWOT Analysis
SWOT Analysis - Overview
AbbVie Inc - Strengths
AbbVie Inc - Weaknesses
AbbVie Inc - Opportunities
AbbVie Inc - Threats
AbbVie Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
AbbVie Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 28, 2017: AbbVie and M2Gen Announce New Collaboration for the Oncology Research Information Exchange Network (ORIEN) Avatar Research Program
Jan 27, 2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results
Jan 09, 2017: AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance
Oct 28, 2016: AbbVie Reports Third-Quarter 2016 Financial Results
Aug 16, 2016: R-Pharm and AbbVie Announce Launch of Project on Localization of Production of Viekira Pak to Treat Chronic Hepatitis C in Russia
Jul 29, 2016: AbbVie Reports Second-Quarter 2016 Financial Results
Jun 03, 2016: AbbVie to Highlight its Innovative Pipeline to the Investment Community
Apr 28, 2016: AbbVie Reports First-Quarter 2016 Financial Results
Apr 04, 2016: IXICO Joins Global Parkinson’s Consortium
Feb 23, 2016: Major pharma companies sign up to groundbreaking Parkinson’s consortium
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
AbbVie Inc, Key Facts
AbbVie Inc, Key Employees
AbbVie Inc, Key Employee Biographies
AbbVie Inc, Major Products and Services
AbbVie Inc, Number of Pipeline Products by Therapy Area
AbbVie Inc, Number of Pipeline Products by Therapy Area (Cont...1)
AbbVie Inc, Number of Pipeline Products by Development Stage
AbbVie Inc, History
AbbVie Inc, Subsidiaries
AbbVie Inc, Key Competitors
AbbVie Inc, Ratios based on current share price
AbbVie Inc, Annual Ratios
AbbVie Inc, Annual Ratios (Cont...1)
AbbVie Inc, Annual Ratios (Cont...2)
AbbVie Inc, Interim Ratios
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
AbbVie Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
AbbVie Inc, Pipeline Products by Therapy Area
AbbVie Inc, Pipeline Products by Development Phase
AbbVie Inc, Performance Chart (2012 - 2016)
AbbVie Inc, Ratio Charts
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
AbbVie Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology and general medicine therapy areas. Its products are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, osteoarthritis, plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, chronic lymphocytic leukemia, small cell lung cancer, relapsed/refractory marginal zone lymphoma, Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, hepatitis C (HCV), human immunodeficiency virus (HIV) and other serious health conditions. AbbVie sells its products worldwide directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its owned distribution centers and public warehouses. The company operates through subsidiaries in North America, South America, Asia, Europe, Middle East and South Africa. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc Key Recent Developments

Mar 28,2017: AbbVie and M2Gen Announce New Collaboration for the Oncology Research Information Exchange Network (ORIEN) Avatar Research Program
Jan 27,2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results
Jan 09,2017: AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance
Oct 28,2016: AbbVie Reports Third-Quarter 2016 Financial Results
Sep 28,2016: AbbVie Opens First Phase of its Global Manufacturing Facility in Singapore to Support the Growth of its Pipeline

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;